XIDX
TPIA
Market cap33bUSD
Nov 12, Last price
7,025.00IDR
Name
Chandra Asri Petrochemical Tbk PT
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Chandra Asri Pacific Tbk provides chemical and infrastructure solutions in Indonesia and Singapore. It operates through Energy, Chemical, and Infrastructure segments. The company offers olefins, such as ethylene, propylene, pyrolysis gasoline, crude C4, and pyrolysis fuel oil. It also provides polyolefins comprising polyethylene products, including linear low density and high-density polyethylene under the Asrene brand name; and polypropylene products, such as homopolymer, random and impact copolymer, and terpolymer under the Trilene brand name for use in food packaging, housewares, electronics, and automotive products. The company offers styrene monomer, an organic monomer aromatics compound for use in the production of polystyrene, expanded polystyrene, styrene acrylonitrile, acrylonitrile butadiene styrene, styrene butadiene rubber, styrene butadiene latex, and unsaturated polyester resin; butadiene, a conjugated diene to produce styrene-butadiene rubber, adhesives, sealants, coatings, and other rubber products; and raffinate-1 and chlor alkali products. It also engages in the sale of electricity and other electrical services, as well as fuels; wholesale business; leasing of tanks and jetty; and management consulting, warehousing, storage, water treatment, and seaport services. The company offers ethylene dichloride, a chemical input to produce polyvinyl chloride; butene-1, an organic chemical used as a co-monomer of polyethylene polymerization; methyl tert-butyl ether (MTBE), a volatile organic compound; and raffinate-2, a by-product of MTBE used as feedstock. It also exports its products. The company was formerly known as PT Chandra Asri Petrochemical Tbk and changed its name to PT Chandra Asri Pacific Tbk in January 2024. The company was founded in 1984 and is headquartered in Jakarta, Indonesia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||